KR950005319A - 약학적 조성물 - Google Patents

약학적 조성물 Download PDF

Info

Publication number
KR950005319A
KR950005319A KR1019940019227A KR19940019227A KR950005319A KR 950005319 A KR950005319 A KR 950005319A KR 1019940019227 A KR1019940019227 A KR 1019940019227A KR 19940019227 A KR19940019227 A KR 19940019227A KR 950005319 A KR950005319 A KR 950005319A
Authority
KR
South Korea
Prior art keywords
pharmaceutical composition
inhibitor
glucosidase
lipase inhibitor
tetrahydrolipstatin
Prior art date
Application number
KR1019940019227A
Other languages
English (en)
Other versions
KR100342285B1 (ko
Inventor
브레머 클라우스-디에터
사블레빅쯔 파벨
Original Assignee
프리돌린 클라우스너, 롤란드 보러
에프.호프만-라 롯슈 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프리돌린 클라우스너, 롤란드 보러, 에프.호프만-라 롯슈 아크티엔게젤샤프트 filed Critical 프리돌린 클라우스너, 롤란드 보러
Publication of KR950005319A publication Critical patent/KR950005319A/ko
Application granted granted Critical
Publication of KR100342285B1 publication Critical patent/KR100342285B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

활성 물질로서 글루코시다제 및/또는 아밀라제 억제제 및 리파제 억제제와 유용한 약학적 담체를 함유하는 약학적 제제.

Description

약학적 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 활성 물질로서 글루코시다제 및/또는 아밀라제 억제제 및 리파제 억제제와 유용한 약학적 담체를 함유하는 약학적 제제.
  2. 제1항에 있어서, 활성 물질로서 아카르보제 및 테트라하이드로립스타틴을 함유하는 제제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019940019227A 1993-08-05 1994-08-04 약학제제 KR100342285B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2339/93 1993-08-05
CH233993 1993-08-05

Publications (2)

Publication Number Publication Date
KR950005319A true KR950005319A (ko) 1995-03-20
KR100342285B1 KR100342285B1 (ko) 2002-10-25

Family

ID=4231504

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940019227A KR100342285B1 (ko) 1993-08-05 1994-08-04 약학제제

Country Status (24)

Country Link
US (1) US5643874A (ko)
EP (1) EP0638317B1 (ko)
JP (1) JP2780932B2 (ko)
KR (1) KR100342285B1 (ko)
CN (1) CN1076196C (ko)
AT (1) ATE190503T1 (ko)
AU (1) AU684793B2 (ko)
BR (1) BR9403170A (ko)
CA (1) CA2128044C (ko)
CZ (1) CZ286202B6 (ko)
DE (1) DE59409200D1 (ko)
DK (1) DK0638317T3 (ko)
ES (1) ES2144019T3 (ko)
GR (1) GR3033643T3 (ko)
HU (1) HU222346B1 (ko)
IL (1) IL110510A (ko)
NO (1) NO313490B1 (ko)
NZ (1) NZ264142A (ko)
PL (1) PL175997B1 (ko)
PT (1) PT638317E (ko)
RU (1) RU2141844C1 (ko)
SA (1) SA94150156B1 (ko)
TW (1) TW381025B (ko)
ZA (1) ZA945673B (ko)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004996A (en) * 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
ATE292975T1 (de) * 1997-02-05 2005-04-15 Hoffmann La Roche Verwendung von tetrahydolipstatin in der behandlung von diabetes typ ii
HU9701081D0 (en) * 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
GB9727131D0 (en) 1997-12-24 1998-02-25 Knoll Ag Therapeutic agents
US6267952B1 (en) * 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
DE19802700A1 (de) * 1998-01-24 1999-07-29 Bayer Ag Verfahren zur Herstellung einer im Mund schnell zerfallenden Arzneiform, die als Wirkstoff Acarbose enthält
WO2000009122A1 (en) * 1998-08-14 2000-02-24 F. Hoffmann-La Roche Ag Pharmaceutical compositions containing lipase inhibitors
EP1112063A4 (en) * 1998-09-08 2009-05-13 Smithkline Beecham Corp TABLETS BASED ON AN LPSTATINE DERIVATIVE AND SOLUBLE FIBERS
AU2542500A (en) * 1999-01-22 2000-08-07 Hunza Di Maria Carmela Marazzita S.A.S. Lipoprotein complexes and compositions containing them
AR025587A1 (es) * 1999-09-13 2002-12-04 Hoffmann La Roche Formulaciones en dispersion que contienen inhibidores de lipasa
US6235305B1 (en) * 1999-10-29 2001-05-22 2Pro Chemical Essentially nonabsorbable lipase inhibitor derivatives, pharmaceutical compositions and methods of use therefor
US6348492B1 (en) * 1999-10-29 2002-02-19 2Pro Chemical Oxetanone derivatives
US6342519B2 (en) * 1999-10-29 2002-01-29 2 Pro Chemical Oxetanone derivatives
EP1144377A4 (en) * 1999-10-29 2002-05-02 John Jason Gentry Mullins OXETANONE DERIVATIVES
KR100349334B1 (ko) * 1999-12-08 2002-08-21 박관화 아카비오신 글루코실 시몬진 및 그것의 제조방법.
US7713546B1 (en) 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
JP4265911B2 (ja) * 2000-07-28 2009-05-20 エフ．ホフマン−ラ ロシュ アーゲー 新規医薬組成物
AU2001289696B2 (en) * 2000-07-28 2006-07-06 Cheplapharm Arzneimittel Gmbh New use of lipase inhibitors
US6849609B2 (en) * 2001-04-10 2005-02-01 James U. Morrison Method and composition for controlled release acarbose formulations
WO2003047531A2 (en) 2001-12-04 2003-06-12 Biogal Gyogyszergyar Rt Preparation of orlistat and orlistat crystalline forms
US7108869B2 (en) * 2002-11-07 2006-09-19 Access Business Group International Llc Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
US20060185357A1 (en) * 2004-05-07 2006-08-24 Kovacevich Ian D Independently drawing and tensioning lines with bi-directional rotary device having two spools
ES2639802T3 (es) 2004-05-10 2017-10-30 University Of Copenhagen Linazas para control del peso corporal
US20060029567A1 (en) 2004-08-04 2006-02-09 Bki Holding Corporation Material for odor control
ES2328384T3 (es) * 2004-11-23 2009-11-12 Warner-Lambert Company Llc Derivados del acido 7-(2h-pirazol-3-il)-3,5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de la lipidemia.
US8283312B2 (en) * 2005-02-04 2012-10-09 The Research Foundation Of State University Of New York Compositions and methods for modulating body weight and treating obesity-related disorders
US20060229261A1 (en) * 2005-04-12 2006-10-12 John Devane Acarbose methods and formulations for treating chronic constipation
WO2006119038A1 (en) * 2005-04-29 2006-11-09 Naturegen, Inc. Compositions and methods for controlling glucose uptake
US20090208584A1 (en) * 2005-06-09 2009-08-20 Tomohiro Yoshinari Solid preparation
CA2617654A1 (en) * 2005-08-04 2007-02-08 Pfizer Limited Piperidinoyl-pyrrolidine and piperidinoyl-piperidine compounds
CN100349614C (zh) * 2005-10-21 2007-11-21 南京工业大学 一种含α－淀粉酶抑制剂的固体混合物及其制备工艺和在制药中的应用
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US20070104805A1 (en) * 2005-11-01 2007-05-10 Udell Ronald G Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
EA200801738A1 (ru) * 2006-02-23 2008-12-30 Пфайзер Лимитед Пиперидиноилпирролидиновые агонисты меланокортинового рецептора 4 типа
TW200831497A (en) * 2006-10-12 2008-08-01 Epix Delaware Inc Carboxamide compounds and their use
KR20090064478A (ko) 2006-11-13 2009-06-18 화이자 프로덕츠 인크. 디아릴, 디피리디닐 및 아릴-피리디닐 유도체, 및 이들의 용도
US20080182851A1 (en) * 2006-11-20 2008-07-31 Glenmark Pharmaceuticals S.A. Acetylene derivatives as stearoyl coa desaturase inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
PL2002825T3 (pl) * 2007-06-14 2013-12-31 Krka Kompozycje farmaceutyczne zawierające orlistat
US9066536B2 (en) * 2007-09-12 2015-06-30 University Of Copenhagen Compositions and methods for increasing the suppression of hunger and reducing the digestibility of non-fat energy satiety
WO2009037542A2 (en) 2007-09-20 2009-03-26 Glenmark Pharmaceuticals, S.A. Spirocyclic compounds as stearoyl coa desaturase inhibitors
MX2010004072A (es) * 2007-10-15 2010-09-14 Inventis Dds Pvt Ltd Composicion farmaceutica de orlistat.
KR20100102646A (ko) 2007-12-11 2010-09-24 가부시키가이샤 사이토파스파인더 카르복스아미드 화합물 및 케모카인 수용체 길항제로서의 이의 용도
AU2009278838B2 (en) * 2008-08-06 2013-07-25 Pfizer Limited Diazepine and diazocane compounds as MC4 agonists
JP5752359B2 (ja) * 2010-02-25 2015-07-22 富士フイルム株式会社 体重増加抑制組成物及びこれを含む食品
EP2571860A1 (en) 2010-05-21 2013-03-27 Pfizer Inc 2-phenyl benzoylamides
TR201100148A2 (tr) * 2011-01-06 2012-07-23 Bi̇lgi̇ç Mahmut Stabil akarboz förmülasyonları.
US20130345392A1 (en) 2011-03-04 2013-12-26 Pfizer Inc Edn3-like peptides and uses thereof
CN102805744A (zh) * 2011-06-02 2012-12-05 鲁南制药集团股份有限公司 一种治疗或预防肥胖症以及代谢综合症的药物组合物
CN102872062A (zh) * 2011-07-13 2013-01-16 鲁南制药集团股份有限公司 一种治疗或预防肥胖症以及代谢综合症的药物组合物
US8252312B1 (en) * 2011-12-27 2012-08-28 David Wong Oral solid composition comprising a lipid absorption inhibitor
WO2013133685A1 (en) 2012-03-09 2013-09-12 Biotropics Malaysia Berhad Extract formulations of rhodamnia cinerea and uses thereof
WO2013167995A2 (en) * 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of hyperglycemia
EP2986599A1 (en) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
FR3017536B1 (fr) 2014-02-18 2017-05-26 Univ La Rochelle Compositions pour la prevention et/ou le traitement de pathologies liees a l'alpha-glucosidase
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CA2970991C (en) * 2014-12-17 2021-08-03 Goran Alderborn A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders
KR101903150B1 (ko) 2016-09-12 2018-10-01 가톨릭대학교산학협력단 퀴니자린을 유효성분으로 포함하는 비만 예방 또는 치료용 조성물
CN107308154A (zh) * 2017-07-19 2017-11-03 重庆植恩药业有限公司 治疗或预防肥胖症以及代谢综合征的药物组合物及其应用
CA3125765A1 (en) 2019-01-18 2020-07-23 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
JPS5953920B2 (ja) * 1977-12-28 1984-12-27 東洋醸造株式会社 新規なアミノ糖化合物およびその製法
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
JPS56128774A (en) * 1980-03-14 1981-10-08 Microbial Chem Res Found New physiologically active substance ebelactone and its preparation
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
DK520784A (da) * 1984-01-21 1985-07-22 Hoechst Ag Cycliske polypeptider, deres fremstilling og anvendelse
US4952567A (en) * 1988-05-09 1990-08-28 City Of Hope Inhibition of lipogenesis
CA1329127C (en) * 1988-08-22 1994-05-03 Takao Matsuo Calcium absorption promoter
DK244090D0 (da) * 1990-10-09 1990-10-09 Novo Nordisk As Kemiske forbindelser
US5240962A (en) * 1991-04-15 1993-08-31 Takasago Institute For Interdisciplinary Science, Inc. Antiobesity and fat-reducing agents
GB9122051D0 (en) * 1991-10-17 1991-11-27 Univ Nottingham Medicines

Also Published As

Publication number Publication date
EP0638317B1 (de) 2000-03-15
DE59409200D1 (de) 2000-04-20
PT638317E (pt) 2000-07-31
TW381025B (en) 2000-02-01
PL304557A1 (en) 1995-02-06
HU9402249D0 (en) 1994-09-28
IL110510A0 (en) 1994-11-11
CA2128044C (en) 2007-02-20
PL175997B1 (pl) 1999-03-31
JP2780932B2 (ja) 1998-07-30
CZ182594A3 (en) 1995-02-15
IL110510A (en) 1999-03-12
CN1076196C (zh) 2001-12-19
ES2144019T3 (es) 2000-06-01
DK0638317T3 (da) 2000-06-26
ZA945673B (en) 1995-02-07
NO942900D0 (ko) 1994-08-04
US5643874A (en) 1997-07-01
AU684793B2 (en) 1998-01-08
BR9403170A (pt) 1995-04-18
RU94028653A (ru) 1996-09-10
ATE190503T1 (de) 2000-04-15
CZ286202B6 (cs) 2000-02-16
CN1106701A (zh) 1995-08-16
CA2128044A1 (en) 1995-02-06
JPH0753409A (ja) 1995-02-28
GR3033643T3 (en) 2000-10-31
AU6883994A (en) 1995-02-16
NO313490B1 (no) 2002-10-14
NZ264142A (en) 1996-11-26
EP0638317A1 (de) 1995-02-15
HU222346B1 (hu) 2003-06-28
SA94150156B1 (ar) 2005-05-15
HUT68300A (en) 1995-06-28
KR100342285B1 (ko) 2002-10-25
RU2141844C1 (ru) 1999-11-27
NO942900L (no) 1995-02-06

Similar Documents

Publication Publication Date Title
KR950005319A (ko) 약학적 조성물
ES2195970T3 (es) L-ribavirina y usos de la misma.
ES2100874T3 (es) Soporte para muestras de perfume.
ES2146774T3 (es) Polimeros de ioneno que contienen aniones biologicamente activos.
KR910004173A (ko) 치조농루 예방껌
KR920703071A (ko) 지질 저하제로서 콜레스티라민을 함유하는 미세정제
DE69814135D1 (de) 7-substituierte chinazolin-2,4-dionen verwendbar als antibakterielle mittel
BR9908427A (pt) Composições farmacêuticas e uso das mesmas
KR940008689A (ko) 항네프로제증후군제
ES2091280T3 (es) Composicion detergente liquida que contiene lipasa y proteasa.
KR910009279A (ko) 세포 보호제 조성물
KR890011588A (ko) 간 섬유증 억제제
KR940008690A (ko) 에리트로포이에틴 항빈혈작용 증강제
DE3873016T2 (de) Optisch aktive, delta-valerolacton-ring enthaltende verbindung und dieselbe enthaltende fluessigkristalline zusammensetzung.
KR930016096A (ko) 상처 치유 촉진용 조성물
KR910011285A (ko) 운데실렌산 에스테르를 사용하는 분뇨용 탈취제
KR850007366A (ko) 서방성(徐放性) 입상 농약
KR870003689A (ko) 살충 조성물
ATE155644T1 (de) Mikrobizide mittel
KR910000106A (ko) 발모촉진제
AR003452A1 (es) Dimaleato de n,n-dietil-8,8-dipropil-2-azaspiro [4.5]decano-2-propanamina y una composicion farmaceutica que lo comprende.
KR910021410A (ko) 신규 올리고펩티드 및 안지오텐신 변환효소저해제
KR830004782A (ko) 논용 제초제 조성물
KR870003785A (ko) 급성 위염치료제
KR900011444A (ko) 모발 영양제

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130531

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20140529

Year of fee payment: 13

EXPY Expiration of term